Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Form:
solution
Quality level:
General description
Manufactured for Sigma by Boston Biochem., Inc.
Application
Proteasome Fraction II is ideal for demonstrating ubiquitin- and ATP-dependent degradation/conjugation of radiolabeled or immunodetectable substrates. Isopeptidase inhibitor and a proteasome inhibitor are highly recommended for the accumulation of ubiquitin protein conjugates. Typical assay concentration for FII is 0.5 - 4 mg/ml.
Biochem/physiol Actions
Essentially ubiquitin and ATP free. Contains E1, most E2s, UCHs, and the proteasome 20S and 26S isoforms.
Protein fraction of a cell extract that binds to anion-exchange resin.
Physical form
Solution in 25 mM HEPES, pH 7.6.
Storage Class
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
A Hershko et al.
The Journal of biological chemistry, 261(26), 11992-11999 (1986-09-15)
In order to gain insight into the mechanisms that determine the selectivity of the ubiquitin proteolytic pathway, the protein substrate binding site of the ubiquitin-protein ligase system was identified and examined. Previous studies had shown that the ligase system consists
A Hershko et al.
The Journal of biological chemistry, 258(13), 8206-8214 (1983-07-10)
By affinity chromatography of a crude reticulocyte extract on ubiquitin-Sepharose, three enzymes required for the conjugation of ubiquitin with proteins have been isolated. One is the ubiquitin-activating enzyme (E1), which is covalently linked to the affinity column in the presence
Global Trade Item Number
| SKU | GTIN |
|---|---|
| F4051-5MG | 04061833261712 |